U.S. Acinetobacter Pneumonia Therapeutics Market Sees Pfizer Driving Innovation as Global Market Expands from USD 842.6 million in 2026 to USD 1,596.6 million by 2036 at a 6.6%. CAGR ROCKVILLE, MARYLAND , August 25, 2026 – The Acinetobacter pneumonia therapeutics market is projected to grow from USD 842.6 million in 2026 to USD 1,596.6 million by 2036, recording a compound...

U.S. AI Drug Repurposing Market Gains Momentum as Pfizer Expands AI-Driven Drug Discovery, with Global Market Rising from USD 1.5 billion in 2026  to USD 8.8 billion by 2036 at a 19.4% CAGR ROCKVILLE, MARYLAND , August 24, 2026 — The AI drug repurposing market crossed a valuation of USD 1.3 billion in 2025. Demand is projected to increase from USD 1.5 billion in 2026...

ROCKVILLE, MARYLAND , August 14, 2026 — The Artificial Intelligence in Ultrasound Imaging Market is valued at USD 3.9 billion in 2026 and is forecast to reach USD 16.8 billion by 2036, recording a compound annual growth rate of 15.7%. The market surpassed USD 3.4 billion in 2025. Absolute opportunity is projected at USD 12.9 billion by 2036, led by Image Analysis Software,...

U.S. Drug Reference Apps Market Expands as Wolters Kluwer Advances Clinical Decision Support, with Global Market Rising from USD 2.2 billion in 2026 to USD 5.6 billion by 2036 at a 9.7% CAGR ROCKVILLE, MARYLAND , August 24, 2026 — The drug reference apps market reached USD 2.0 billion in 2025. Demand is projected to increase from USD 2.2 billion in 2026 to USD 5.6 billion...

ROCKVILLE, MARYLAND , August 14, 2026 — The edge AI medical software market reached USD 3.3 billion in 2025. Demand is projected to increase from USD 3.7 billion in 2026 to USD 12.8 billion by 2036, registering a compound annual growth rate (CAGR) of 13.2%. An absolute opportunity of USD 9.1 billion is expected between 2026 and 2036. Get detailed market forecasts,...

ROCKVILLE, MARYLAND , August 14, 2026 — The healthcare agentic artificial intelligence market reached USD 3.2 billion in 2025. Demand is projected to rise from USD 3.9 billion in 2026 to USD 24.6 billion by 2036, recording a compound annual growth rate of 20.2% over the 2026–2036 forecast period and creating an absolute opportunity of USD 20.7 billion. Get detailed...

U.S. Erythropoietin (EPO) Drugs Market Strengthens as Amgen Leads Innovation, with Global Market Rising from USD 13.8 billion in 2026 to USD 22.7 billion by 2036 at a 5.1% CAGR ROCKVILLE, MARYLAND , August 24, 2026 — The global erythropoietin (EPO) drugs market is projected to grow from USD 13.8 billion in 2026 to USD 22.7 billion by 2036, registering a compound annual...

U.S. Solid Tumor Testing Market Advances as Thermo Fisher Scientific Expands Precision Oncology, with Global Market Rising from USD 32.9 billion in 2026 to USD 65.9 billion by 2036 at a 7.2% CAGR ROCKVILLE, MARYLAND , August 24, 2026 — The global solid tumor testing market reached a valuation of USD 30.7 billion in 2025. Demand is projected to expand from USD...

U.S. Veterinary CRO & CDMO Market Expands as Charles River Laboratories Strengthens Animal Health R&D, with Global Market Rising from USD 7.5 billion in 2026 to USD 16.2 billion by 2036 at a 8.0% CAGR ROCKVILLE, MARYLAND , August 24, 2026 -According to the latest market study by Fact.MR (Report Code: FACT15845MR), the global Veterinary CRO CDMO Market stood at USD 6.9...